AstraZeneca has gained approval from the European Commission for its oral therapy, Tagrisso (osimertinib), to treat adults with NSCLC.

Hiring strategies for 2025 need to look different, as factors including AI and the demand for flexibility are changing the ...

Pfizer has gained accelerated approval from the US FDA for BRAFTOVI in conjunction with cetuximab and mFOLFOX6 for treating mCRC.

Precision has gained the approval of its CTA in Hong Kong to study PBGENE-HBV in the Phase I trial for curing chronic hepatitis B.

What’s a busy HR professional to do now? You were so looking forward to spending the holidays planning for compliance with the Department of ...